Predictive value of toll-like receptors, myeloid differentiation factor 88, and nuclear factor kappa-B regarding the response to Bacillus Calmette-Guérin intravesical therapy in patients with high-risk non-muscle-invasive bladder cancer: A controlled cohort clinical study.

Zahran AA, Shokeir AA, Serria MS, Awadalla A, El-Gamal R, Elshabrawy I, Baiomy AA

Open source

DOI
10.1016/j.urolonc.2026.05.026
Published
2026 Sep
Container
Urologic oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.urolonc.2026.05.026,
  title = {Predictive value of toll-like receptors, myeloid differentiation factor 88, and nuclear factor kappa-B regarding the response to Bacillus Calmette-Guérin intravesical therapy in patients with high-risk non-muscle-invasive bladder cancer: A controlled cohort clinical study.},
  author = {Zahran AA and Shokeir AA and Serria MS and Awadalla A and El-Gamal R and Elshabrawy I and Baiomy AA},
  year = {2026},
  journal = {Urologic oncology},
  doi = {10.1016/j.urolonc.2026.05.026},
  url = {https://doi.org/10.1016/j.urolonc.2026.05.026}
}

RIS

TY  - JOUR
TI  - Predictive value of toll-like receptors, myeloid differentiation factor 88, and nuclear factor kappa-B regarding the response to Bacillus Calmette-Guérin intravesical therapy in patients with high-risk non-muscle-invasive bladder cancer: A controlled cohort clinical study.
AU  - Zahran AA
AU  - Shokeir AA
AU  - Serria MS
AU  - Awadalla A
AU  - El-Gamal R
AU  - Elshabrawy I
AU  - Baiomy AA
PY  - 2026
JO  - Urologic oncology
DO  - 10.1016/j.urolonc.2026.05.026
UR  - https://doi.org/10.1016/j.urolonc.2026.05.026
ER  - 

APA

AA, Z., AA, S., MS, S., A, A., R, E., I, E., & AA, B. (2026). Predictive value of toll-like receptors, myeloid differentiation factor 88, and nuclear factor kappa-B regarding the response to Bacillus Calmette-Guérin intravesical therapy in patients with high-risk non-muscle-invasive bladder cancer: A controlled cohort clinical study.. Urologic oncology. https://doi.org/10.1016/j.urolonc.2026.05.026

Source records